Abstract
Silica xerogel-chitosan hybrids containing vancomycin were fabricated by the sol–gel process at room temperature and their potential as a drug eluting bone replacement was evaluated in terms of their mechanical properties and drug release behaviors. Regardless of the content of chitosan, all of the prepared hybrids had a uniform mesoporous structure, which would allow the effectual loading of vancomycin. As the content of chitosan was increased, the strength, strain to failure, and work of fracture of the hybrids were significantly enhanced, while the elastic modulus was decreased. These changes in the mechanical properties were mainly attributed to the mitigation of the brittleness of the silica xerogel through its hybridization with the flexible chitosan phase. In addition, the initial burst-effect was remarkably reduced by increasing the content of chitosan. The hybrids with more than 30% chitosan could release the vancomycin for an extended period of time in a controlled manner.
Similar content being viewed by others
References
Aza PND, Guititi F, Aza SD. Bioeutectic: a new ceramic material for human bone replacement. Biomaterials. 1997;18:1285–91.
Lemons JE. Ceramics: past, present, and future. Bone. 1996;19:1219–88.
Vassilis K, David K. Porosity of 3D biomaterial scaffolds and osteogenesis (Review). Biomaterials. 2005;26:5474–91.
Coombes AGA, Meikle MC. Resorbable synthetic polymers as replacements for bone graft. Clin Mater. 1994;17:35–67.
Hing AK. Bone repair in the twenty-first century: biology, chemistry or engineering. Phil Trans R Soc Lond A. 2004;362:2821–50.
Teller M, Gopp U, Neumann HG, Kuhn KD. Release of gentamicin from bone regenerative materials: an in vitro study. J Biomed Mater Res B. 2007;81:23–9.
Le Ray AM, Chiffoleau S, Iooss P, Grimandi G, Gouyette A, Daculsi G, et al. Vancomycin encapsulation in biodegradable poly(ε-caprolactone) microparticles for bone implantation. Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility. Biomaterials. 2003;24:443–9.
Pedro GR, Clement S. Functional hybrid materials. : Wiley-VCH Verlag GmbH & Co. KGaA; 2004.
Radin S, Ducheyne P, Kamplain T, Tan BH. Silica sol–gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release. J Biomed Mater Res. 2001;57:313–20.
Meseguer-Olmo L, Ros-Nicolas MJ, Clavel-Sainz M, Vicente-Ortega V, Alcaraz-Banos M, Lax-Perez A, et al. Biocompatibility and in vivo gentamicin release from bioactive sol–gel glass implants. J Biomed Mater Res. 2002;61:458–65.
Choi D, Marra KG, Kumta PN. Chemical synthesis of hydroxyapatite/poly(e-caprolactone) composites. Mater Res Bull. 2004;39:417–32.
Reis RL, Cunha AM, Oliveira MJ, Campos AR, Bevis MJ. Relationship between processing and mechanical properties of injection molded high molecular mass polyethylene + hydroxyapatite composites. Mat Res Innovat. 2001;4:263–72.
Kim HW, Knowles JC, Kim HE. Hydroxyapatite/poly(ε-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials. 2004;25:1279–87.
Laurencin CT, Attawi MA, Lu LQ, Borden MD, Lu HH, Gorum WJ, et al. Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: A regional gene therapy approach to bone regeneration. Biomaterials. 2001;22:1271–7.
Komlev VS, Barinova SM, Koplik EV. A method to fabricate porous spherical hydroxyapatite granules intended for time-controlled drug release. Biomaterials. 2002;23:3449–54.
Lee EJ, Shin DS, Kim HE, Kim HW, Koh YH, Jang JH. Membrane of hybrid chitosan–silica xerogel for guided bone regeneration. Biomaterial. 2009;30:743–50.
Hamadouche M, Meunier A, Greenspan DC, Blanchat C, Zhong JP, La Torre GP, et al. Long-term in vivo bioactivity and degradability of bulk sol–gel bioactive glasses. J Biomed Mater Res. 2001;54:560–6.
Li P, Ye X, Kangasniemi I, de Blieck-Hogervorst JMA, Klein CPAT, de Groot K. In vivo calcium phosphate formation induced by sol–gel-prepared silica. J Biomed Mater Res A. 1995;29:325–8.
Radina S, El-Bassyounia G, Vresilovicb EJ, Schepersc E, Ducheyne P. In vivo tissue response to resorbable silica xerogels as controlled-release materials. Biomaterials. 2005;26:1043–52.
Nilsen E, Einarsrud MA, Scherer GW. Effect of precursor and hydrolysis conditions on drying shrinkage. J Non-Cryst Solids. 1997;221:135–43.
Avnir D, Coradin T, Lev O, Livage J. Recent bio-applications of sol–gel materials. J Mater Chem. 2006;16:1013–30.
Mosquera MJ, de los Santos DM, Valdez-Castro L, Esquivias L. New route for producing crack-free xerogels: obtaining uniform pore size. J Non-Cryst Solids. 2008;354:645–50.
Radin S, Falaizea S, Lee MH, Ducheyne P. In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials. Biomaterials. 2002;23:3113–22.
Aughenbaugh W, Radin S, Ducheyne P. Silica sol–gel for the controlled release of antibiotics. II. The effect of synthesis parameters on the in vitro release kinetics of vancomycin. J Biomed Mater Res. 2001;57:321–6.
Martino AD, Sittinger M, Risbud MV. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials. 2005;26:5983–90.
Tunney MM, Brady AJ, Buchanan F, Newe C, Dunne NJ. Incorporation of chitosan in acrylic bone cement: Effect on antibiotic release, bacterial biofilm formation and mechanical properties. J Mater Sci: Mater Med. 2008;19:1609–15.
Ueno H, Yamada H, Tanaka I, Kaba N, Matsuura M, Okumura M, et al. Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials. 1999;20:1407–14.
Trung TS, Thein-Han WW, Qui NT, Ng CH, Stevens WF. Functional characteristics of shrimp chitosan and its membranes as affected by the degree of deacetylation. Biores Tech. 2006;97:659–63.
Silva SS, Ferreira RAS, Fu L, Carlos LD, Mano JF, Reis RL, et al. Functional nanostructured chitosan–siloxane hybrids. J Mater Chem. 2005;15:3952–61.
Bandyopadhyay A, Bhowmick AK, Sarkar MD. Synthesis and characterization of acrylic rubber/silica hybrid composites prepared by sol–gel technique. J Appl Polym Sci. 2004;93:2579–89.
Chen X, Jia J, Dong S. Organically modified sol–gel/chitosan composite based glucose biosensor. Electroanalysis. 2003;15:608–12.
Blouin RA, Bauer LA, Miller DD, Record KE, Griffen WO Jr. Vancomycin pharmacokinetics in normal and morbidly obese subjects. Antimicrob Agents Chemother. 1982;21:575–80.
Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123–33.
Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev. 2006;58:387–401.
Rothstein SN, Federspiel WJ, Little SR. A unified mathematical model for the prediction of controlled release from surface and bulk eroding polymer matrices. Biomaterials. 2009;30:1657–64.
Patterson J, Stayton PS, Li X. In situ characterization of the degradation of PLGA microspheres in hyaluronic acid hydrogels by optical coherence tomography. IEEE Trans Med Imaging. 2009;28:74–81.
Ahola MS, Sailynoja ES, Raitavuo MH, Vaahtio MM, Salonen JI, Yli-Urpo AUO. In vitro release of heparin from silica xerogels. Biomaterials. 2001;22:2163–70.
Morpurgo M, Teoli D, Palazzo B, Bergamin E, Realdon N, Guglielmi M. Influence of synthesis and processing conditions on the release behavior and stability of sol–gel derived silica xerogels embedded with bioactive compounds. Farmaco. 2005;60:675–83.
Pancholi K, Ahras N, Stride E, Edirisinghe M. Novel electrohydrodynamic preparation of porous chitosan particles for drug delivery. J Mater Sci: Mater Med. 2009;20:917–23.
Zhao L, Chang J, Zhai WY. Preparation and HL-7702 cell functionality of titania/chitosan composite scaffolds. J Mater Sci: Mater Med. 2009;20:949–57.
Lu X, Wang Y, Liu Y, Wang J, Qu S, Feng B, et al. Preparation of HA/chitosan composite coatings on alkali treated titanium surfaces through sol–gel techniques. Mater Lett. 2007;61:3970–3.
Acknowledgments
This research was supported by a grant from the Fundamental R&D Program for Core Technology of Materials funded by Ministry of Knowledge Economy, Republic of Korea.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, EJ., Jun, SH., Kim, HE. et al. Silica xerogel-chitosan nano-hybrids for use as drug eluting bone replacement. J Mater Sci: Mater Med 21, 207–214 (2010). https://doi.org/10.1007/s10856-009-3835-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-009-3835-9